Spero Therapeutics Inc
NASDAQ:SPRO

Watchlist Manager
Spero Therapeutics Inc Logo
Spero Therapeutics Inc
NASDAQ:SPRO
Watchlist
Price: 2.41 USD 0.42% Market Closed
Market Cap: 135.8m USD

Wall Street
Price Targets

SPRO Price Targets Summary
Spero Therapeutics Inc

Wall Street analysts forecast SPRO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SPRO is 4.08 USD with a low forecast of 4.04 USD and a high forecast of 4.2 USD.

Lowest
Price Target
4.04 USD
68% Upside
Average
Price Target
4.08 USD
69% Upside
Highest
Price Target
4.2 USD
74% Upside
Spero Therapeutics Inc Competitors:
Price Targets
2616
CStone Pharmaceuticals
128% Upside
MDGL
Madrigal Pharmaceuticals Inc
23% Upside
BAVA
Bavarian Nordic A/S
28% Upside
SBTX
SkinBioTherapeutics PLC
53% Upside
603087
Gan & Lee Pharmaceuticals
9% Downside
INSM
Insmed Inc
35% Upside
688105
Nanjing Vazyme Biotech Co Ltd
32% Upside
LCTX
Lineage Cell Therapeutics Inc
131% Upside

Revenue
Forecast

Revenue Estimate
Spero Therapeutics Inc

For the last 8 years the compound annual growth rate for Spero Therapeutics Inc's revenue is 86%. The projected CAGR for the next 4 years is -8%.

86%
Past Growth
-8%
Estimated Growth
Estimates Accuracy
25%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Spero Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
Spero Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-62%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SPRO's stock price target?
Price Target
4.08 USD

According to Wall Street analysts, the average 1-year price target for SPRO is 4.08 USD with a low forecast of 4.04 USD and a high forecast of 4.2 USD.

What is Spero Therapeutics Inc's Revenue forecast?
Projected CAGR
-8%

For the last 8 years the compound annual growth rate for Spero Therapeutics Inc's revenue is 86%. The projected CAGR for the next 4 years is -8%.

Back to Top